SINGAPORE: A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild COVID-19.
"The main purpose of the study is to assess how Lian Hua Qing Wen Jiao Nang capsules, when given in addition to current standard medical treatment, may have a complementary effect on the time to COVID-19 symptom recovery in fully vaccinated adults with mild COVID-19 and who are on home recovery in Singapore," said HSA.
On HSA's clinical trial registry, Dr Ong Sze Tat from Ubi Family Clinic and Surgery and Dr Zuraimi Mohamed Dahlan from Banyan Clinic @ JW are listed as the study's principal investigators.
Allah SWT mengajar umat Islam mengenai Pakistan tetapi mereka tidak memahami begitu juga dgn rakyat Pakistan. Muhammad Qasim melihat bahawa Pakistan mempunyai kepentingan utama dalam Islam dan masa depan umat Islam. Ketahui lebih lanjut tentang hal ini di
« Singapore trial » means Singapore will study other countries’ studies. Cute.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: thenewpaper - 🏆 7. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »